Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OPCML - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101060363 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ECM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNFAIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEBL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DACT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SSR4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DHCR7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM38 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AFDN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCKAR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIP10 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GLUL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MECP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSME4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIOS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HAUS5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TLR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYFIP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on